Core Insights - HuiZhiWei, established in November 2011, is a leading domestic RF front-end chip company that went public on May 16, 2023, on the Shanghai Stock Exchange [1] Group 1: Business Performance - In Q3 2025, HuiZhiWei reported revenue of 568 million yuan, ranking 19th among 34 companies in the industry, with the industry leader, WitsView, generating 3.521 billion yuan [2] - The revenue composition includes 195 million yuan from 5G modules (55.01%) and 159 million yuan from 4G modules (44.80%) [2] - The net profit for the same period was -122 million yuan, placing the company 29th in the industry, with the industry leader achieving a net profit of 677 million yuan [2] Group 2: Financial Ratios - As of Q3 2025, HuiZhiWei's debt-to-asset ratio was 24.86%, higher than the previous year's 15.56% and above the industry average of 16.92%, indicating increased debt pressure [3] - The gross profit margin was reported at 7.77%, significantly lower than the industry average of 36.44%, although it improved from 1.13% in the previous year [3] Group 3: Management and Shareholder Information - The chairman and general manager, Li Yang, received a salary of 1.0887 million yuan in 2024, an increase of 11,000 yuan from the previous year [4] - As of September 30, 2025, the number of A-share shareholders increased by 9.39% to 17,700, while the average number of circulating A-shares held per shareholder decreased by 8.59% [5] Group 4: Market Outlook - In the first half of 2025, the company achieved revenue of 355 million yuan, a year-on-year increase of 39.97%, while the net profit was -65 million yuan, reducing losses by 118 million yuan [6] - The company is expected to benefit from stable shipments to platform customers and Samsung, with new products like Phase8L L-PAMID entering mass production [6] - Investment recommendations suggest a target price of 17.20 yuan, maintaining a "buy" rating, with revised revenue forecasts for 2025-2027 [6]

Core Viewpoint - The company HuiZhiWei (688512.SH) reported a significant increase in revenue for Q3 2025, but also posted a net loss attributed to shareholders. Financial Performance - The company's operating revenue reached 213 million yuan, representing a year-on-year increase of 63.73% [1] - The net profit attributable to shareholders was -57.11 million yuan [1] - The net profit attributable to shareholders, excluding non-recurring gains and losses, was -68.33 million yuan [1]

证券代码：688512 证券简称：慧智微 公告编号：2025-041 广州慧智微电子股份有限公司 关于注销2021年股票期权激励计划部分股票期权的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 广州慧智微电子股份有限公司（以下简称"公司"）于2025年10月30日召开第二 届董事会第九次会议，审议通过了《关于注销2021年股票期权激励计划部分股票期权 的议案》。鉴于1名持有1.80万份已授予但尚未行权股票期权的激励对象因离职已不符 合《2021年股票期权激励计划》中有关激励对象的规定，以及本激励计划第二个行权 期第一期激励对象的行权期已于2025年9月30日结束，激励对象尚有19.50万份当期股 票期权未行权，董事会根据《2021年股票期权激励计划》的规定，同意注销共计21.30 万份股票期权，现将具体情况公告如下： 一、股权激励计划方案及履行程序 2021年3月29日，广州慧智微电子有限公司（下称"慧智有限"）做出董事会决议， 为了达到对核心员工的激励并吸引优秀人才加盟，公司董事会审议通过期权激励方案： 期权预留总 ...

关于广州慧智微电子股份有限公司 2021 年股票期权 激励计划之第三个行权期第一期激励对象行权条件 成就及注销部分股票期权的 法律意见书 二〇二五年十月 北京市中伦（广州）律师事务所 法律意见书 北京市中伦（广州）律师事务所 关于广州慧智微电子股份有限公司 2021 年股票期权激励计划之 第三个行权期第一期激励对象行权条件成就及注销部分股票期 权的法律意见书 致：广州慧智微电子股份有限公司 北京市中伦（广州）律师事务所（简称"本所"）受广州慧智微电子股份有 限公司（简称"慧智微"、"公司"）的委托，作为慧智微 2021 年股票期权激励计 划第三个行权期第一期激励对象行权条件成就（以下简称"本次行权"）及注销 2021 年股票期权激励计划部分股票期权（以下简称"本次注销"）的相关事宜的 法律顾问，就本次行权及本次注销的相关事宜进行核查，并出具本法律意见书。 本所根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共 和国证券法》（以下简称"《证券法》"）、中国证券监督管理委员会（以下简称"中 国证监会"）颁发的《上市公司股权激励管理办法》（以下简称"《管理办法》"） 等法律、法规及规范性文件以及《 ...

证券代码：688512 证券简称：慧智微 公告编号：2025-043 广州慧智微电子股份有限公司 关于召开 2025 年第三季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 投资者可于 2025 年 11 月 6 日（星期四）至 11 月 12 日（星期三）16:00 前登 录 上 证 路 演 中 心 网 站 首 页 点 击 " 提 问 预 征 集 " 栏 目 或 通 过 公 司 邮 箱 db@smartermicro.com 进行提问。公司将在说明会上对投资者普遍关注的问题进 行回答。 广州慧智微电子股份有限公司（以下简称"公司"）已于 2025 年 10 月 31 日发布公司 2025 年第三季度报告，为便于广大投资者更全面深入地了解公司 2025 年第三季度的经营成果、财务状况，公司计划于 2025 年 11 月 13 日（星期 四）上午 9:00-10:00 举行 2025 年第三季度业绩说明会，就投资者关心的问题进 行交流。 一、说明会类型 本次业绩说明会以网络互动形式召开，公司将 ...

Revenue and Profit - The company's revenue for the third quarter reached ¥213,328,498.48, representing a year-on-year increase of 63.73%[4] - The total profit for the period was -¥56,865,273.82, with a year-to-date total profit of -¥122,249,717.25[4] - The net profit attributable to shareholders was -¥57,111,145.12 for the quarter, and -¥122,389,531.86 year-to-date[4] - The total profit for the first three quarters was -122.25 million yuan, a decrease in loss of 59.01% compared to the same period last year[10] - The net profit attributable to shareholders for the first three quarters was -122.39 million yuan, with a reduction in loss of 58.98% year-on-year[10] - The total comprehensive income attributable to the parent company for the period was -122,389,531.86 CNY, compared to -298,349,583.30 CNY in the same period last year, indicating an improvement[23] Earnings Per Share - The basic and diluted earnings per share were both -¥0.12 for the quarter, compared to -¥0.26 year-to-date[5] - The basic earnings per share for the first three quarters was -0.26 yuan/share, a decrease in loss of 59.48% compared to the previous year[10] - The diluted earnings per share for the third quarter was -0.12 yuan/share, reflecting a decrease in loss of 50.90% year-on-year[10] - Basic and diluted earnings per share were both -0.26 CNY, an improvement from -0.65 CNY year-over-year[23] Research and Development - Research and development expenses totaled ¥53,711,467.06, accounting for 25.18% of revenue, a decrease of 27.71 percentage points compared to the previous year[5] - Research and development expenses decreased to ¥153,030,614.14 in 2025 from ¥209,633,013.41 in 2024, reflecting a 27% reduction[22] Cash Flow - The company experienced a year-to-date cash flow from operating activities of -¥250,468,355.97[4] - Cash inflows from operating activities totaled 713,699,573.93 CNY, up from 381,025,047.93 CNY in the previous year, representing an increase of approximately 87.3%[25] - Cash outflows from operating activities increased to 964,167,929.90 CNY from 655,678,892.64 CNY, resulting in a net cash flow from operating activities of -250,468,355.97 CNY, slightly improved from -274,653,844.71 CNY[25] - Cash inflows from investment activities were 977,125,390.28 CNY, down from 2,133,637,615.50 CNY, reflecting a decrease of approximately 54.3%[25] - Cash outflows from investment activities were 1,007,945,593.96 CNY, compared to 2,014,011,379.01 CNY, resulting in a net cash flow from investment activities of -30,820,203.68 CNY, a decline from 119,626,236.49 CNY[25] - Cash inflows from financing activities increased to 366,225,479.78 CNY from 112,582,914.50 CNY, marking a significant increase of approximately 225.5%[26] - Net cash flow from financing activities was 226,795,260.77 CNY, compared to 107,848,845.06 CNY in the previous year, indicating a substantial improvement[26] - The ending cash and cash equivalents balance was 770,702,816.09 CNY, down from 843,952,903.27 CNY year-over-year[26] Assets and Liabilities - Total assets increased by 4.23% to ¥2,305,304,501.11 compared to the end of the previous year[5] - Total current assets increased to ¥1,582,462,892.94 as of September 30, 2025, compared to ¥1,485,969,042.38 at the end of 2024, marking a growth of 6.5%[17] - Total liabilities rose to ¥573,108,384.73 in 2025, up from ¥405,367,867.98 in 2024, representing an increase of 41.4%[18] - The company's total assets reached ¥2,305,304,501.11 as of September 30, 2025, an increase from ¥2,211,677,058.74 at the end of 2024[18] - The company's equity attributable to shareholders decreased to ¥1,732,196,116.38 in 2025 from ¥1,806,309,190.76 in 2024, a decline of 4.1%[19] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 17,739[12] - The largest shareholder, Li Yang, holds 36,431,200 shares, accounting for 7.80% of the total shares[12] Government Subsidies - The company reported non-recurring gains of ¥11,222,515.38 for the period, with government subsidies contributing ¥7,742,226.14[7] - The company received increased government subsidies related to revenue compared to the previous year, which positively impacted financial performance[10] Financial Reporting Consistency - The company has not applied new accounting standards or interpretations for the current year, ensuring consistency in financial reporting[27]

广州慧智微电子股份有限公司 董事会薪酬与考核委员会 关于2021年股票期权激励计划第三个行权期第一期可 行权激励对象名单的核查意见 根据《中华人民共和国公司法》(以下简称"《公司法》")、《中华人民共和国证券法》 《上市公司股权激励管理办法》《上海证券交易 所科创板股票上市规则》《科创板上市公 司自律监管指南第4号——股权激励信息披露》等相关法律、法规、规范性文件、《广州 慧智微电子股份有限公司章程》以及广州慧智微电子股份有限公司(以下简称"公司")2021 年第一次临时股东大会审议通过的《广州慧智微电子股份有限公司2021年股票期权激励 计划（草案）》(以下简称"《2021年股票期权激励计划》")的规定，董事会薪酬与考核委 员会对公司2021年股票期权激励计划第三个行权期第一期可行权的48名激励对象名单进 行了核查，发表核查意见如下： 一、公司符合《上市公司股权激励管理办法》和《2021年股票期权激励计划》规定的 实施股权激励计划的条件，公司具备实施股权激励计划的主体资格，未发生规定中的不得 行权的情形。 （5）法律法规规定不得参与上市公司股权激励的； （6）中国证监会认定的其他情形； 三、激励对象中不存在 ...

证券代码：688512 证券简称：慧智微 公告编号：2025-040 广州慧智微电子股份有限公司 第二届董事会第九次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、会议召开情况 广州慧智微电子股份有限公司（以下称"公司"）第二届董事会第九次会议于 2025年10月30日以现场结合通讯方式召开。本次会议通知以电子邮件方式发出，会 议应出席董事6人，实际出席董事6人。本次会议由董事长李阳先生主持。会议的召集、 召开以及表决程序均符合《中华人民共和国公司法》和《广州慧智微电子股份有限公 司章程》的有关规定，会议合法有效。 二、会议审议情况 经与会董事认真讨论审议，以记名投票表决方式，审议通过如下议案： 1、审议通过《关于注销2021年股票期权激励计划部分股票期权的议案》 表决。 具体内容详见公司于2025年10月31日在上海证券交易所网站（www.sse.com.cn） 披露的《关于注销2021年股票期权激励计划部分股票期权的公告》（公告编号：2025- 041）。 2、审议通过《关于2021年股票期权激励计划 ...

证券代码：688512 证券简称：慧智微 公告编号：2025-042 广州慧智微电子股份有限公司 关于2021年股票期权激励计划第三个行权期第一期激励对象行权 条件成就的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 广州慧智微电子股份有限公司（以下简称 "公司"）于2025年10月30日召开第二 届董事会第九次会议，审议通过了《关于2021年股票期权激励计划第三个行权期第一 期激励对象行权条件成就的议案》，现将具体情况公告如下： 一、股权激励计划批准及实施情况 （一）股票期权激励计划方案及履行程序 2021年3月29日，广州慧智微电子有限公司（下称"慧智有限"）做出董事会决议， 为了达到对核心员工的激励并吸引优秀人才加盟，公司董事会审议通过期权激励方案： 期权预留总额550万份，对应行权后550万元注册资本，可行权时间为公司上市后，若 公司行权前发生资本公积转增股本、净资产折股、派发股票红利、股份拆细或缩股、 配股、派息等事宜的，则预留期权份数及对应的行权后可取得注册资本数量将相应调 整；期权行权价 ...

Group 1 - Dingjide's subsidiary has successfully launched the industrial production of POE materials, achieving stable production of qualified products [1] - Xinhua Insurance reported a 19% year-on-year increase in original insurance premium income for the first three quarters, totaling 172.705 billion yuan [1] - Chunfeng Power achieved a 30.89% year-on-year increase in net profit for the first three quarters, with total revenue reaching 14.15 billion yuan [1][2] Group 2 - Guangsheng Nonferrous expects a net profit of 100 million to 130 million yuan for the first three quarters, marking a turnaround from losses [1] - Aobi Zhongguang anticipates a net profit of approximately 108 million yuan for the first three quarters, with revenue growth of 103.5% [1] - Guobang Pharmaceutical reported a 15.78% year-on-year increase in net profit for the first three quarters, totaling 6.7 billion yuan [1] Group 3 - Zhujiang Co. manages 428 projects with a signed construction area of approximately 50.9853 million square meters as of September 2025 [1] - Kecuan Technology has terminated its application for issuing convertible bonds, considering its development plan and actual situation [1] - Guoxin Securities has received approval to register 15 billion yuan in short-term corporate bonds [1] Group 4 - Aihua Pharmaceutical's clinical trial for a pediatric cough syrup has been approved by the National Medical Products Administration [1] - Xinjiang Jiaojian signed new construction contracts worth 1.413 billion yuan in the third quarter [1] - Sichuan Shuangma's subsidiary has received approval for the listing of a raw material drug used in treating various diseases [1] Group 5 - Gansu Energy's 1,000 MW coal-fired unit has officially commenced commercial operation [1] - Zhejiang Energy reported a 4.68% year-on-year increase in power generation for the first three quarters, totaling 135.234 billion kWh [1] - Tiandi Source's contract sales amount for the first nine months decreased by 16.18% to 3.085 billion yuan [1] Group 6 - Biological Shares' subsidiary has obtained a new veterinary drug registration certificate for a vaccine [1] - Jintong Co. reported a 4.03% year-on-year increase in net profit for the first three quarters, totaling 2.283 billion yuan [1] - Rihua Technology plans to invest 800 million yuan in a new project for industrial ray detection equipment [1] Group 7 - Zhongtian Technology has won multiple marine project bids totaling approximately 1.788 billion yuan [1] - Qingsong Co. has completed the disposal of a 148-acre industrial park project, transferring it for 163 million yuan [1] - Tongyuan Petroleum has successfully bid for a $126 million oil and gas service project in Algeria [1] Group 8 - Hengmingda's chairman proposed a share buyback plan of 200 million to 400 million yuan [1] - Deyi Cultural plans to reduce its holdings by up to 1% of the company's shares [1] - Feirongda's major shareholder plans to reduce its holdings by up to 2.36% of the company's shares [1] Group 9 - Mankun Technology plans to issue convertible bonds to raise no more than 760 million yuan for high-end PCB production and digital upgrades [1] - Sanlian Forging's shareholder plans to reduce its holdings by up to 3% of the company's shares [1] - Huagong Technology intends to jointly establish a venture capital fund with a target size of 500 million yuan [1] Group 10 - Shida Shenghua expects a net loss of 49 million to 75 million yuan for the first three quarters [1] - Huichuangda's major shareholder plans to reduce its holdings by up to 0.65% of the company's shares [1] - Yuxin Electronics reported a 60.21% year-on-year increase in net profit for the first three quarters, totaling 73.3941 million yuan [1] Group 11 - Yiwei Communication expects a 50% to 55% decline in net profit for the first three quarters [1] - Lio Co. plans to reduce its repurchased shares by up to 135 million shares [1] - Sichuan Shuangma's subsidiary has received approval for a new drug registration [1]